Rapid Tests Kits OTG USA COVID-19 Rapid Urine Antibody Test (World's First and Only) COVID-19 IgG / IgM Rapid Antibody Detection Test COVID-19 Saliva Antigen Rapid POC Test COVID-19 Antigen Rapid POC Test (Nasal Swab Collection)
Hello,Sir Or Madam! Good News For You! I'm Tony Tsui, The Executive Of Runway Group. We Runway Group have successfully R&D the New Very Hot Hot Hot Product :COVID-19 Antibody Rapid Test kits .This Has been used and inspected by many hospitals In Wuhan And China Other Cities ,Now,our test kit FDA&CE Approved Certificates,it can sell all the world. It Is very hot product For many countries ,many governments ,many Hospitals for all the World! Now We Wanted The Exclusive Agent In Your Country in all the world! CIFCustomer Country Unit Price :xx Usd/pcs ,MOQ:0.2million Pcs ,3-5 working days shipment. When We Received 100% Prepayment By T/T or L/C AT SIGHT.
Our SARS-CoV-2 IgM/IgG Antibody Test Kits are single-use rapid immunochromatographic tests for the qualitative detection and differentiation of Immunoglobulin M(IgM) and Immunoglobulin G(IgG) antibodies to SARS-CoV-2 in human serum, plasma (heparin, dipotassium EDTA, and sodium citrate), and venous whole blood (heparin, dipotassium EDTA, and sodium citrate). They are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Immune colloidal gold technique kit This product is used to qualitative detection of the presence of IgM and/or IgG antibody to SARS-CoV-2 in Human serum, plasma and whole blood. The common symptoms are fever, cough, polypnea and anhelation when infected with SARS-CoV-2. In more serious cases, infection may cause pneumonia, severe acute respiratory syndrome, renal failure and even death. Coronavirus can be excreted through respiratory secretions and transmitted by air droplet. Infection may be caused by saliva, sneeze and contact.
I am the manufacturer of COVID-19 RAPID TEST in China. The ACtest COVID-19 IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM anti-nCoV-19 virus in human whole blood, serum or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with nCoV-19 viruses. The product has obtained the CE certification and is on the list of government export permits. And has been exported to Thailand, the Philippines, Germany, Italy, Ecuador, South Africa and other countries.
SCREEN TEST COVID-19 A rapid test for the qualitative detection of IgG and IgM antibodies to 2019-nCov, Sars-CoV-2 in human Fingerstick Whole Blood specimens. For professional in vitro diagnostic use only. The Sars-CoV-2, 2019-nCOV IgG/IgM Rapid Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to 2019-nCovâ?¦ country of origin : Italy Quality certificates : CE Certificate
Features & Benefits Fast results as soon as 2-10 minutes Facilitates patient treatment decisions quickly Simple, time-saving procedure Little specimens, only 5 �µL of serum/plasma or 10 µL of whole blood specimens All necessary reagents provided & no equipment needed High sensitivity and specificity Specification 25 Tests/Kit Specimen: Whole Blood/Serum/Plasma
Contraindications, precautions, warnings, and instructions: Found that the original packaging is damaged and prohibited to use. Sterilized with ethylene oxide. Contact Directly This products is limited to one-time use and is it destroyed after use. Prohibited to use after the expiration date.
General Information One-Step Dengue Rapid Test is to detect the NS1 antigens and IgG&IgM antibodies in human blood. Sensitivity : 99.9% Specificity : 99.5 % Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min
* Manufactured by Guangzhou Wondfu Biotech Co., Ltd, the leading and publicly traded corporation authorized to manufacture and distribute COVID anti-body rapid tests * Diagnosis for COVID-19 with instant result in 15 minutes * Detection for both IgG and IgM antibody
INTENDED USE For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 infection. FEATURES Coated with carefully selected specific Nucleocapsid and Spike protein antigen. Detection for IgM and IgG antibodies simultaneously. Simple operation, easy result interpreted. Rapid test within 15 minutes. RESULTS INTERPRETATION Positive: 1. The presence of 3 red lines (T1, T2 and C) within the reaction window, no matter which band appears first, indicates presence of both SARS-CoV-2 IgM and IgG antibodies. 2. The presence of 2 red lines (T1 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgM antibody. 3. The presence of 2 red lines (T2 and C) within the reaction window, no matter which band appears first, indicates presence of SARS-CoV-2 IgG antibody. Negative: 1. The presence of line (control line) only within the reaction window indicates that no SARS-CoV-2 antibodies are detected. The results is negative. Invalid: 1. If the control(C) line is not displayed in 10-15 min, regardless of whether T1 and/or T2 line is present, the test result is invalid. It is recommended that the specimen should be re-tested. 2. The test result is invalid after 15 min. CLINICAL PERFORMANCE - Positive Percent Agreement (PPA) = 91.07% (153/168) (95% CI: 85.70%-94.92%). - Negative Percent Agreement (NPA) = 95.37% (103/108) (95% CI: 89.53%-98.48%). - Overall Rates of Agreement (ORA) = 92.75% [(153+103)/ (168+108)] (95% CI: 89.03%-95.52%). [Product Name]: SARS-CoV-2 IgM/IgG Duo Test [Product Code]: Cat# FP-319 [Sample Type]: Whole blood /Plasma/Serum [Sample Volume]: 20L /10L/10L [Detection Method]: Colloidal Gold [Reaction Time]: 10-15min [Packing Size]: 1T x 20 cassettes per box + Sample diluent 1 vial x 5mL. [Storage Condition]: 2oC ~ 30oC [Shelf Life]: 12 months [CE Mark Registration No.]: RPS/499/2021.
Quick Details Type: Pathological Analysis Equipments Brand Name: Caya Medical Place of Origin: Turkey Instrument classification: Class I Certificate: CE
Diagnostic Kit for IgM/IgG 2 in 1 Antibody to 2019-nCoV (Colloidal Gold) Test principle This diagnostic kit adopts the principle of colloidal gold immunochromatographic test strip to make qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. Purpose This diagnostic kit is used for making qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. It acts as an early-stage aided diagnostic kit for clinical patients infecting 2019-nCoV, yet it is not the only standard for clinical diagnose. Sample requirements This kit is suitable for human serum (EDTA anticoagulant, heparin anticoagulant, trisodium citrate dihydrate anticoagulant 1:9), human plasma and whole blood samples.
Intended use The one step anti-dengue (igm & igg) tri-line test is a colloidal gold enhanced, rapid immunochromatographic assay for the qualitative detection of antibodies (igm & igg) to dengue virus (dv) in human whole blood, serum or plasma. This test is a screening test, and all positives must be confirmed using an alternate test such as western blot. The test is intended for healthcare professional use only.
INTENDED USE The One Step RV IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Rubella (Virus) in Whole Blood /Serum / Plasma to aid in the diagnosis of RV infection. The test is based on immunochromatography and can give a result within 15 minutes. PRINCIPLE The One Step RV IgG/IgM Test is a qualitative membrane strip based immunoassay for the detection of RV antibodies (IgG and IgM) in Whole Blood /Serum / Plasma. The test device consists of: 1) a burgundy colored conjugate pad containing RV recombinant envelope antigens conjugated with Colloid gold (RV conjugates) and rabbit IgG-gold conjugates,2) a nitrocellulose membrane strip containing two test bands (T1 and T2 bands) and a control band (C band). The T1 band is pre-coated with the antibody for the detection of IgM anti-RV, T2 band is coated with antibody for the detection of IgG anti-RV, and the C band is pre-coated with goat anti rabbit IgG. When an adequate volume of test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgG anti-RV, if present in the specimen, will bind to the RV conjugates. The immunocomplex is then captured by the reagent pre-coated on the T2 band, forming a burgundy colored T2 band, indicating a RV IgG positive test result and suggesting a recent or repeat infection. IgM anti-RV if present in the specimen will bind to the RV conjugates. The immunocomplex is then captured by the reagent coated on the T1 band, forming a burgundy colored T1 band, indicating a RV IgM positive test result and suggesting a fresh infection. Absence of any T bands (T1 and T2) suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit IgG/rabbit IgG-gold conjugate regardless of the color development on any of the T bands. Otherwise, the test result is invalid and the specimen must be retested with another device. Storage and Stability Store as packaged in the sealed pouch at room temperature or refrigerated (4-30â?? or 40-86â??). The test device is stable through the expiration date printed on the sealed pouch. The test must remain in the sealed pouch until use.
Product Name Corona-virus (SARS-CoV-2) (IgM / IgG) Diagnostic Kit Packing Specifications 1 test/bag, 1 test/box, 20 tests/box, 50 tests/box. Intended Use This kit uses immunocolloidal gold chromatography to detect novel coronavirus IgM/IgG antibodies in human serum, plasma or whole blood in vitro. The 2019 novel coronavirus, abbreviated as 2019-nCov, is a new strain of coronavirus discovered in the human body and outbreaked in Wuhan in the end of 2019. The symptoms of the virus are fever, fatigue, dry cough, and progressive dyspnea. In severe cases, the symptoms are acute respiratory distress syndrome, septic shock, metabolic acidosis and coagulation dysfunction that canot be reversed. The virus has been confirmed the capacity of human-to-human transmission; the shortest incubation period of the virus is only 1 day, while the longest is 14 days. The patients in incubation period is contagious and there is no specific treatment for the disease. Once infected with a new virus, the body's immune system will start to defend and produce specific antibodies. Generally, IgM antibody will appear in 1-2 weeks and IgG antibody will appear in 4 weeks.
General Information One-Step Chagas IgG/IgM Rapid Test is detection of IgG anti-Trypanosoma cruzi (T. cruzi) in human blood. Sensitivity: 92.9% , Specificity: 100% Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
Intended use: Toxoplasma IGG/IGM rapid test is a rapid immunochromatographic test for the simultaneous detection of IGM and IGG antibodies to toxoplasma gondii in human serum/plasma. The test can be used as a screening test for toxoplasma infection and as an aid for differential diagnosis of the self limiting primary toxoplasma infections and the potentially fatal secondary toxoplasma infections in conjunction with other criteria. Test principle: The toxoplasma IGG/IGM rapid test is a lateral flow chromatographic immunoassay. The test cassette consists of: 1) A burgundy colored conjugate pad containing toxoplasma recombinant envelope antigens conjugated with colloid gold (toxoplasma conjugates) and rabbit igg-gold conjugates, 2) A nitrocellulose membrane strip containing two test bands (t1 and t2 bands) and a control band (c band). The t1 band is pre-coated with the antibody for the detection of IGM anti-toxoplasma, t2 band is coated with antibody for the detection of igg anti-toxoplasma, and the c band is pre-coated with goat anti rabbit IGG. Absence of any t bands (t1 and t2) suggests a negative result. The test contains an internal control (c band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit igg/rabbit igg-gold conjugate regardless of the color development on any of the t bands. Otherwise, the test result is invalid and the specimen must be retested with another device. Reagents and materials supplied : 1. Test cassette individually foil pouched with a desiccant. 2. Plastic dropper 3. Buffer 4. Package insert. Storage and stability: The kit must be stored at 2-30pc. Warning and precautions: 1. For in vitro diagnostic use only. Not for medicinal use. 2. Do not use beyond expiry date. 3. Read the instructions careful y before performing the test. 4. Handle all specimen as potential y infectious. 5. Follow standard biosafety guidelines for handling and disposal of potential y infective material.
SARS-CoV-2 IgG/IgM Cartridge Kit include : 1 Test Box + 1 Cartridge + 1 UV Touch SARS-CoV-2 IgG/IgM Kit is used for rapid and accurate screening of the COVID-19, which helps identify suspected patients and reduce false negative rate. Rapid detection of recent SARS-CoV-2 infection In ONLY 12 minutes ONE-STEP operation Single cartridge, NO additional buffers TRFIA Europium particles displays Clear and Bright results Dual capturing antigens (S and N) enhanced sensitivity Important complement to PCR detection in COVID-19 diagnosis
